Identification of TP53 germline variants in pediatric patients undergoing tumor testing: strategy and prevalence.

MLA

Luo, Minjie, et al. “Identification of TP53 Germline Variants in Pediatric Patients Undergoing Tumor Testing: Strategy and Prevalence.” Journal of the National Cancer Institute, vol. 116, no. 8, Aug. 2024, pp. 1356–65. EBSCOhost, https://doi.org/10.1093/jnci/djae102.

APA

Luo, M., Wong, D., Zelley, K., Wu, J., Schubert, J., Denenberg, E. H., Fanning, E. A., Chen, J., Gallo, D., Golenberg, N., Patel, M., Conlin, L. K., Maxwell, K. N., Wertheim, G. B., Surrey, L. F., Zhong, Y., Brodeur, G. M., MacFarland, S. P., & Li, M. M. (2024). Identification of TP53 germline variants in pediatric patients undergoing tumor testing: strategy and prevalence. Journal of the National Cancer Institute, 116(8), 1356–1365. https://doi.org/10.1093/jnci/djae102

Chicago

Luo, Minjie, Derek Wong, Kristin Zelley, Jinhua Wu, Jeffery Schubert, Elizabeth H Denenberg, Elizabeth A Fanning, et al. 2024. “Identification of TP53 Germline Variants in Pediatric Patients Undergoing Tumor Testing: Strategy and Prevalence.” Journal of the National Cancer Institute 116 (8): 1356–65. doi:10.1093/jnci/djae102.